Quantitative Assessment of Lung Volumes and Enhancement in Patients with COVID-19: Role of Dual-Energy CT

Dual-energy computed tomography (DECT) has been used for detecting pulmonary embolism, but the role of lung perfusion DECT as a predictor of prognosis of coronavirus disease 2019 (COVID-19) has not been defined yet. The aim of our study was to explore whether the enhancement pattern in COVID-19+ patients relates to the disease outcome. A secondary aim was to compare the lung volumes in two subgroups of patients. In this observational study, we considered all consecutive COVID-19+ patients who presented to the emergency room between January 2021 and December 2021 with respiratory symptoms (with mild to absent lung consolidation) and were studied by chest contrast-enhanced DECT to be eligible. Two experienced radiologists post-processed the images using the “lung-analysis” software (SyngoVia). Absolute and relative enhancement lung volumes were assessed. Patients were stratified in two subgroups depending on clinical outcome at 30 days: (i) good outcome (i.e., discharge, absence of clinical or imaging signs of disease); (ii) bad outcome (i.e., hospitalization, death). Patient sub-groups were compared using chi-square test or Fisher test for qualitative parameters, chi-square test or Spearman’s Rho test for quantitative parameters, Students’ t-test for parametric variables and Wilcoxon test for non-parametric variables. We enrolled 78 patients (45M), of whom, 16.7% had good outcomes. We did not observe any significant differences between the two groups, both in terms of the total enhancement evaluation (p = 0.679) and of the relative enhancement (p = 0.918). In contrast, the average lung volume of good outcome patients (mean value of 4262 mL) was significantly larger than that of bad outcome patients (mean value of 3577.8 mL), p = 0.0116. All COVID-19+ patients, with either good or bad outcomes, presented similar enhancement parameters and relative enhancements, underlining no differences in lung perfusion. Conversely, a significant drop in lung volume was identified in the bad outcome subgroup eligible compared to the good outcome subgroup.

[1]  K. Nikolaou,et al.  AI Lung Segmentation and Perfusion Analysis of Dual-Energy CT Can Help to Distinguish COVID-19 Infiltrates from Visually Similar Immunotherapy-Related Pneumonitis Findings and Can Optimize Radiological Workflows , 2021, Tomography.

[2]  B. Yin,et al.  Performances of clinical characteristics and radiological findings in identifying COVID-19 from suspected cases , 2021, BMC Medical Imaging.

[3]  Sang Min Lee,et al.  Dual-Energy CT for Pulmonary Embolism: Current and Evolving Clinical Applications , 2021, Korean journal of radiology.

[4]  C. Stroszczynski,et al.  Severe COVID-19 pneumonia: Perfusion analysis in correlation with pulmonary embolism and vessel enlargement using dual-energy CT data , 2021, PloS one.

[5]  R. Aoki,et al.  Imaging of COVID-19: An update of current evidences , 2021, Diagnostic and Interventional Imaging.

[6]  K. Hansen,et al.  Acute Pulmonary Embolism Severity Assessment Evaluated with Dual Energy CT Perfusion Compared to Conventional CT Angiographic Measurements , 2021, Diagnostics.

[7]  M. Kalra,et al.  Qualitative and quantitative DECT pulmonary angiography in COVID-19 pneumonia and pulmonary embolism , 2021, Clinical Radiology.

[8]  S. Gerber,et al.  Dual-energy CT angiography reveals high prevalence of perfusion defects unrelated to pulmonary embolism in COVID-19 lesions , 2021, Insights into Imaging.

[9]  F. Sardanelli,et al.  Dual-energy CT performance in acute pulmonary embolism: a meta-analysis , 2021, European Radiology.

[10]  A. Harky,et al.  The role of computed tomography scan in the diagnosis of COVID-19 pneumonia , 2021, Current opinion in pulmonary medicine.

[11]  D. Shen,et al.  Lung volume reduction and infection localization revealed in Big data CT imaging of COVID-19 , 2020, International Journal of Infectious Diseases.

[12]  T. Kwee,et al.  Chest CT in COVID-19: What the Radiologist Needs to Know , 2020, Radiographics : a review publication of the Radiological Society of North America, Inc.

[13]  G. Remuzzi,et al.  Immunity, endothelial injury and complement-induced coagulopathy in COVID-19 , 2020, Nature Reviews Nephrology.

[14]  A. Malhotra,et al.  Multisystem Imaging Manifestations of COVID-19, Part 1: Viral Pathogenesis and Pulmonary and Vascular System Complications , 2020, Radiographics : a review publication of the Radiological Society of North America, Inc.

[15]  T. Bley,et al.  Comparison of Dual- and Single-Source Dual-Energy CT for Diagnosis of Acute Pulmonary Artery Embolism , 2020, RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren.

[16]  S. Mirsadraee,et al.  Dual-Energy CT Pulmonary Angiography (DECTPA) Quantifies Vasculopathy in Severe COVID-19 Pneumonia , 2020, Radiology. Cardiothoracic imaging.

[17]  N. Faccioli,et al.  Identification of pulmonary embolism: diagnostic accuracy of venous-phase dual-energy CT in comparison to pulmonary arteries CT angiography , 2020, European Radiology.

[18]  L. Boussel,et al.  In vivo demonstration of pulmonary microvascular involvement in COVID-19 using dual-energy computed tomography , 2020, European Respiratory Journal.

[19]  D. Andreini,et al.  Role of computed tomography in COVID-19 , 2020, Journal of Cardiovascular Computed Tomography.

[20]  J. Rello,et al.  Lung and kidney perfusion deficits diagnosed by dual-energy computed tomography in patients with COVID-19-related systemic microangiopathy , 2020, European Radiology.

[21]  P. Calame,et al.  COVID-19 pneumonia: microvascular disease revealed on pulmonary dual-energy computed tomography angiography. , 2020, Quantitative imaging in medicine and surgery.

[22]  David H. Kim,et al.  RadioGraphics Update: Venous Thrombosis and Hypercoagulability in the Abdomen and Pelvis—Findings in COVID-19 , 2020, Radiographics : a review publication of the Radiological Society of North America, Inc.

[23]  Navid Rabiee,et al.  Point-of-Use Rapid Detection of SARS-CoV-2: Nanotechnology-Enabled Solutions for the COVID-19 Pandemic , 2020, International journal of molecular sciences.

[24]  M. Orsi,et al.  Chest computed tomography findings of COVID-19 pneumonia: pictorial essay with literature review , 2020, Japanese Journal of Radiology.

[25]  P. Emery,et al.  Immune mechanisms of pulmonary intravascular coagulopathy in COVID-19 pneumonia , 2020, The Lancet Rheumatology.

[26]  Matthew D. Li,et al.  Hypoxaemia related to COVID-19: vascular and perfusion abnormalities on dual-energy CT , 2020, The Lancet Infectious Diseases.

[27]  C. Roy,et al.  Acute Pulmonary Embolism in COVID-19 Patients on CT Angiography and Relationship to D-Dimer Levels , 2020, Radiology.

[28]  P. Calame,et al.  Acute Pulmonary Embolism Associated with COVID-19 Pneumonia Detected by Pulmonary CT Angiography , 2020, Radiology.

[29]  D. Utsunomiya,et al.  Ultra-high-resolution computed tomography can demonstrate alveolar collapse in novel coronavirus (COVID-19) pneumonia , 2020, Japanese Journal of Radiology.

[30]  R. Maroldi,et al.  COVID-19 outbreak in Italy: experimental chest X-ray scoring system for quantifying and monitoring disease progression , 2020, La radiologia medica.